Business
Poolbeg signs option for new vaccine candidate
Poolbeg signs option for new vaccine candidate.
About this update from Poolbeg Pharma Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 5884U\n Poolbeg Pharma PLC\n 06 December 2021\n \n \n \n \n \n \n \n Poolbeg Pharma plc\n \n \n \n \n \n Poolbeg signs Option Agreement with University College Dublin for a Melioidosis Vaccine\ncandidate, MelioVac, and a licence to evaluate 5 other infectious disease portfolio assets\n \n \n \n \n \n \n 6 December 2021 -\n \n Poolbeg Pharma (AIM: POLB), 'Poolbeg' or the 'Company', a clinical stage infectious disease pharmaceutical company with a capital light clinical model, \n has signed an Option Agreement to licence MelioVac, a vaccine for melioidosis, with University College Dublin ('UCD') and its inventor, Associate Professor Siobhán McClean\n , through NovaUCD, the university's knowledge transfer office.\n \n \n \n The\n Company will continue its due diligence on MelioVac, a preclinical asset and recipient of a Wellcome Trust Award to aid its development, as well as 5 of other potential vaccine candidates discovered by Associate Professor McClean and her team, for the duration of the Option Agreement, prior to signing a 'Licence Agreement'. \n \n \n Dr McClean is Associate Professor and Head of Biochemistry at the UCD School of Biomolecular and Biomedical Science.\n \n Dr McClean completed her BSc in Biochemistry in UCD and received her PhD from Imperial College London. Her research focuses on lung infections which led her to develop a platform technology to identify proteins that bacteria use to attach to human cells. These proteins have proved to be excellent vaccine candidates. Dr McClean completed some of the original research to identify the antigens associated with the Melioidosis Vaccine at TU Dublin.\n \n \n Poolbeg Pharma has identified melioidosis as an infectious disease of interest due to its rising incidence around the world and because there is currently no approved vaccine available. Concerns are growing about global warming contributing to the spread of the disease to traditionally non-tropical areas.\n \n \n Melioidosis, also known as Whitmore's disease, is an infectious disease caused by the bacterium Burkholderia pseudomallei, commonly found in the soil and surface groundwater of many tropical and subtropical regions, with diverse clinical presentations including pneumonia and severe sepsis with multiple organ abscesses. Incidence of the diseas...